Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.
about
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interactionPlasmacytoid dendritic cells: linking innate and adaptive immunityBcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapyInvolvement of CC chemokine ligand 18 (CCL18) in normal and pathological processesIdentification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulationB7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaDendritic cells: In the forefront of immunopathogenesis and vaccine development - A reviewRheumatoid arthritis synovium contains plasmacytoid dendritic cellsImmunologic aspect of ovarian cancer and p53 as tumor antigen.Sensitivity of Dendritic Cells to Microenvironment SignalsCXCR4 in breast cancer: oncogenic role and therapeutic targetingThe Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus AttenuationScanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesRole of mesenchymal cells in the natural history of ovarian cancer: a reviewTranscriptional regulation of chemokine expression in ovarian cancerImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsTargeted immune therapy of ovarian cancerOxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytesStroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesisPathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancerTherapeutic cancer vaccines and combination immunotherapies involving vaccinationImmunosuppressive networks in the tumour environment and their therapeutic relevanceImmunosuppressive strategies that are mediated by tumor cellsAccumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosisThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factorsA novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells.IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1LMyeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinomaTargeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanomaCXCL12 expression by healthy and malignant ovarian epithelial cells.Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.Constitutive non-canonical NFkappaB signaling in pancreatic cancer cellsSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsCD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.
P2860
Q24309134-4D8048C9-F879-4805-9684-621504382AF5Q24558695-98E8A227-14A2-42C5-9220-FE61B165F90EQ24635408-1091043F-AA0D-49CD-950B-AC3752BCBDDFQ24647107-F552DE01-88DE-4CCE-A3D0-6D340EA537D7Q24670416-F332F1D2-AD5F-4E33-94DF-F0D401D4A8A2Q24676809-9D856FF1-C7EB-41FC-8043-411A368F767AQ24792153-25FBED83-2394-42F6-B660-BF478BC56A85Q24803551-53FED87F-C582-4950-9785-4FF64DF2CC2FQ24814703-315F1AD3-0E5D-47CA-8E60-E8FA13231844Q26752817-8F4D04D2-42F5-4576-8990-AB07BC35DCA7Q26781915-183B1A43-8FC9-4ADD-BD33-F2BD49826B0CQ26795464-46FA51B3-E3EF-4060-8878-4B29E2028CA9Q26798209-45019352-178B-4645-9302-7B68CB4C54CAQ26823555-08069D47-8BCD-4BDF-BBD7-8814B10D13F1Q26825361-66EDE400-42A3-440C-8F7E-F80D3531067DQ26996829-7D3192E8-C3FA-459A-80DB-3D9FC2A5DD8CQ28075712-7FA71A2A-0EAA-4A1E-A415-1EC7014D47D0Q28082828-A1BCFFFA-7AB4-4F5F-9DC9-991E7C06CA4EQ28248592-E6E070C5-0A26-4612-B9D8-BF9F426E9A61Q28260997-2E56EECC-F8DC-41C9-A749-006DDE13E56EQ28392626-88A07D6B-CD80-4071-92DE-3C3B6792460FQ28397609-0FD65B17-331C-4C5C-8708-7DB1A941EE75Q29619244-F6B26F05-2A74-4148-A128-F26294F84AB9Q29636247-92EC5FFB-B3E3-4C3B-8CAA-6B86B1C9367EQ30316394-06F93A1D-BA92-4E7C-A82F-95D8B1B92EFAQ30317628-0B2EB5E4-1844-4DFF-BD7E-D8C1B0ADD44EQ30490975-E0596025-5FC1-4762-8611-0A88E426B896Q33488520-E3EACDA6-0987-4059-BF84-B29F3D1955EDQ33573323-1FA54AB9-B493-4D17-B432-37B21FA80838Q33655332-5EC8FD55-6499-4515-87A1-440AD4080A94Q33757576-8C158E0D-DD30-4655-955E-4EB216ACC9B8Q33834337-6CEF74BE-4B5B-4D72-B588-06DD8F1BDFE2Q33840446-79654479-0C57-4AAF-9734-3FF51A559269Q33848551-0015AB96-ECFF-49F7-8296-69D1587F5C98Q33959320-D49C66E5-921F-4637-B4DF-51F685AA7DD1Q33976734-B6E27AA7-86F8-4B3F-8C8A-532933E3A215Q34021737-A3964D06-6CD6-4E36-90FD-5F98A2F324CDQ34055580-B5BB788C-7F5E-4657-8BD0-30042F697DECQ34063120-A9ED74AF-F384-4B1B-8D89-5C6828664E18Q34476278-3FE2B62A-7050-4370-991A-E3C2FD2283D4
P2860
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@ast
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@en
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@nl
type
label
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@ast
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@en
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@nl
prefLabel
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@ast
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@en
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@nl
P2093
P356
P1433
P1476
Stromal-derived factor-1 in hu ...... oid precursor dendritic cells.
@en
P2093
Coulomb-L'Hermin A
Durand-Gasselin I
Galanaud P
P2888
P304
P356
10.1038/NM1201-1339
P407
P577
2001-12-01T00:00:00Z